A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.
- DOI
- 10.1177/13524585261446829
- Published
- 2026 Sep
- Container
- Multiple sclerosis (Houndmills, Basingstoke, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/13524585261446829,
title = {A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.},
author = {Benallegue N and Rollot F and Iaffaldano P and Lucisano G and Simone M and Lugaresi A and Casey R and Cocco E and Vukusic S and De Luca G and Mathey G and Patti F and Maillart E and Amato MP and Michel L and Fantozzi R and Ciron J and De Robertis F and De Sèze J and Coniglio MG and Ruet A and Filippi M and Labauge P and Crisafulli SG and Zephir H and Ferraro D and Papeix C and Lebrun-Frenay C and Trojano M and Laplaud DA},
year = {2026},
journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
doi = {10.1177/13524585261446829},
url = {https://doi.org/10.1177/13524585261446829}
}RIS
TY - JOUR TI - A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis. AU - Benallegue N AU - Rollot F AU - Iaffaldano P AU - Lucisano G AU - Simone M AU - Lugaresi A AU - Casey R AU - Cocco E AU - Vukusic S AU - De Luca G AU - Mathey G AU - Patti F AU - Maillart E AU - Amato MP AU - Michel L AU - Fantozzi R AU - Ciron J AU - De Robertis F AU - De Sèze J AU - Coniglio MG AU - Ruet A AU - Filippi M AU - Labauge P AU - Crisafulli SG AU - Zephir H AU - Ferraro D AU - Papeix C AU - Lebrun-Frenay C AU - Trojano M AU - Laplaud DA PY - 2026 JO - Multiple sclerosis (Houndmills, Basingstoke, England) DO - 10.1177/13524585261446829 UR - https://doi.org/10.1177/13524585261446829 ER -
APA
N, B., F, R., P, I., G, L., M, S., A, L., R, C., E, C., S, V., G, D. L., G, M., F, P., E, M., MP, A., L, M., R, F., J, C., F, D. R., J, D. S., MG, C., A, R., M, F., P, L., SG, C., H, Z., D, F., C, P., C, L., M, T., & DA, L. (2026). A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/13524585261446829
Source records
- pubmed · retrieved 2026-09-26T12:08:48.504Z